Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery
Open accessAbstract
Targeted drug delivery using nanocarriers is achieved by functionalizing the carrier surface with a tissue-recognition ligand. Current surface modification methods require tedious and inefficient synthesis and purification steps, and are not easily amenable to incorporating multiple functionalities on a single surface. In this report, we describe a versatile, single-step surface functionalizing technique for polymeric nanoparticles. The technique utilizes the fact that when a diblock copolymer like polylactide-polyethylene glycol (PLA-PEG) is introduced in the oil/water emulsion used in polymeric nanoparticle formulation, the PLA block partitions into the polymer containing organic phase and PEG block partitions into the aqueous phase. Removal of the organic solvent results in the formation of nanoparticles with PEG on the surface. When a PLA-PEG-ligand conjugate is used instead of PLA-PEG copolymer, this technique permits a 'one-pot' fabrication of ligand-functionalized nanoparticles. In the current study, the IAASF approach facilitated the simultaneous incorporation of biotin and folic acid, known tumor-targeting ligands, on drug-loaded nanoparticles in a single step. Incorporation of the ligands on nanoparticles was confirmed by using NMR, surface plasmon resonance, transmission electron microscopy and tumor cell uptake studies. Simultaneous functionalization with both ligands significantly enhanced nanoparticle accumulation in tumors in vivo, and resulted in greatly improved efficacy of paclitaxel-loaded nanoparticles in a mouse xenograft tumor model. This new surface functionalization approach will enable the development of targeting strategies based on the use of multiple ligands on a single surface to target a tissue of interest.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Oil-in-water emulsions are common in pharmaceutical development and can be applied to polymer micelle preparation.
“Another technique, oil in water emulsions, is common in pharmaceutical development and can be applied to polymer micelle preparation.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [278]
The Introduction and Materials and Methods describe an oil-in-water emulsion used to make polymeric nanoparticles, and the Results and Discussion describe emulsion solvent evaporation as a method used in drug-delivery nanoparticle formulation. They do not support the claim about preparing polymer micelles: the Results and Discussion explicitly say the particles produced are not micellar, while the Methods say incidental micelles are removed. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 38 · Cited by 242
Research works printed but not linked: 1
- [19]Sahoo SK Ma W Labhasetwar V Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer Int J Cancer 2004 112 335 340 15352049
- Authors
- Patil, Y. B., Toti, U. S., Khdair, A., Ma, L., & Panyam, J.
- Affiliations
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- University of Minnesota (US)
- Masonic Cancer Center (US)
- Corresponding author
- Panyam, Jayanth
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 30
- Issue
- 5
- Pages
- 859-866
- ISSN
- 0142-9612 (ISSN-L)
- PMC
- PMC2637351
- OpenAlex
- W2072750787
- Cited by
- 242
- References
- 38
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 11 · 2023: 6 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 20 · 2018: 15 · 2017: 14 · 2016: 23 · 2015: 12 · 2014: 17 · 2013: 20 · 2012: 14
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R21CA116641)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- polymeric nanoparticles, surface functionalization, targeted drug delivery, diblock copolymers, oil-water emulsions, biotin, folic acid, tumor targeting, paclitaxel, tumor accumulation
- MeSH terms
- Animals, Female, Humans, Neoplasms, Polyesters, Polyethylene Glycols, Polymers, Drug Delivery Systems, Surface Plasmon Resonance, Cell Line, Tumor, Microscopy, Electron, Transmission, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review